Search results for "IPR"

showing 10 items of 1515 documents

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

2011

Abstract Abstract 5302 Background: A multicentre randomized controlled trial (RCT) was designed to assess the effectiveness of long-term sequential deferiprone-deferoxamine (DFO-DFP) versus DFP alone to treat thalassaemia major (TM) (Maggio et al.,2009). Effectviness, survival, adverse events and costs were comparable between the groups. These findings were confirmed in a further 21-month follow-up (Pantalone et al., 2011). Moreover, deferiprone-alone has been reported to be superior to deferoxamine for the removal of cardiac iron and improvement in left ventricular ejection function (LVEF). However, little is known of its relative effect on LVEF after long-term treatment. Therefore, data f…

medicine.medical_specialtyEjection fractionbusiness.industryThalassemiaImmunologyDeferasiroxRetrospective cohort studyCell BiologyHematologymedicine.diseaseBiochemistrylaw.inventionchemistry.chemical_compoundchemistryRandomized controlled triallawHeart failureInternal medicinemedicineCardiologybusinessDeferiproneSurvival analysismedicine.drugBlood
researchProduct

The Efficacy of Rotary, Reciprocating, and Combined Non-Surgical Endodontic Retreatment Techniques in Removing a Carrier-Based Root Canal Filling Mat…

2020

The aim of this study is to analyze and compare the efficacy of three non-surgical endodontic retreatment techniques in removing a carrier-based root canal filling material from straight root canal systems. The study was performed on 99 single-rooted extracted teeth using the ProTaper Gold endodontic rotary system up to the F2 file (Dentsply Maillefer, Baillagues, Switzerland), which were sealed with GuttaCore (Dentsply Maillefer, Ballaigues, Switzerland) and AH plus epoxy resin sealer (Dentsply DeTrey, Konstanz, Germany) and randomly assigned to the following non-surgical retreatment techniques: ProTaper Retreatment endodontic rotary instruments (D1&ndash

medicine.medical_specialtyEndodontics.Root canalEndodoncia.Dentistrylcsh:MedicineArticleDientes - Cavidades - Preparación.03 medical and health sciencesReciprocating motionTeeth - Roots - Planing.0302 clinical medicine0502 economics and businessmedicineTeeth - Tomography.Statistical analysisTeeth - Extraction - Treatment.Materiales dentales.Odontología restauradora.micro-computed tomographyroot canal filling materialEndodontic retreatmentnon-surgical endodontic retreatmentreciprocating movementbusiness.industryMicro computed tomography05 social scienceslcsh:RMaterial removal030206 dentistryGeneral MedicineEndodonticsExtracción dental - Tratamiento.humanitiesDientes - Infecciones - Tratamiento.medicine.anatomical_structureDientes - Tomografía.050211 marketingDental materials.businessTeeth - Infections - Treatment.Dentistry Operative.Journal of Clinical Medicine
researchProduct

Treatment options for leishmaniasis.

2021

Leishmaniasis is broadly classified into three types: cutaneous, mucocutaneous and visceral. The visceral form is most dangerous and can result in death. Although leishmaniasis is an ancient disease, its treatment is still challenging. Several drugs, differing in their cost, toxicity, treatment duration and emergence of drug resistance, are used for different types of leishmaniasis. To overcome these limitations, the search for newer drugs and other treatments continues. In this article, we discuss conventional drugs, other treatments, including newer options such as immunotherapy and immunochemotherapy, and future prospects for leishmaniasis treatment.

medicine.medical_specialtyHot Temperaturemedicine.medical_treatmentTreatment durationMucocutaneous zone610 MedizinAntiprotozoal AgentsDermatologyDiseaseDrug resistance610 Medical sciencesmedicineHumansLeishmaniasisbusiness.industryTreatment optionsLeishmaniasisImmunotherapymedicine.diseaseDermatologyCombined Modality TherapyPhotochemotherapyCryotherapyDrug Therapy CombinationImmunotherapybusinessClinical and experimental dermatologyReferences
researchProduct

Pharmacotherapy of panic attacks.

1988

medicine.medical_specialtyImipraminebusiness.industryPsychopharmacologyPanicGeneral MedicineFearPanicPsychiatry and Mental healthPharmacotherapymedicineHumansPharmacology (medical)medicine.symptomPsychiatrybusinessPharmacopsychiatry
researchProduct

Phosphodiesterase-4 inhibition improves corticosteroid insensitivity in pulmonary endothelial cells under oxidative stress.

2012

Several clinical studies have shown that smoking in asthmatics and chronic obstructive pulmonary disease patients is closely associated with corticosteroid refractoriness. In this work, we have analyzed glucocorticoid insensitivity in human pulmonary artery endothelial cells (HPAECs) under cigarette smoke extract (CSE) exposure as well as the possible additive effects of the combination therapy with a phosphodiesterase (PDE)-4 inhibitor. Interleukin (IL)-8 was measured in cell supernatants by ELISA. Histone deacetylase (HDAC), histone acetylase (HAT), and intracellular cAMP levels were measured by colorimetric assays and enzyme immunoassay, respectively. PDE4 isotypes and glucocorticoid rec…

medicine.medical_specialtyImmunologyApoptosisDexamethasoneHistone DeacetylasesGlucocorticoid receptorReceptors GlucocorticoidAdrenal Cortex HormonesInternal medicinemedicineCyclic AMPImmunology and AllergyHumansReceptorLungDexamethasoneRolipramCell ProliferationHistone AcetyltransferasesChemistryTumor Necrosis Factor-alphaInterleukin-8InterleukinPhosphodiesteraseEndothelial CellsAparato respiratorioCyclic Nucleotide Phosphodiesterases Type 4Enzyme ActivationOxidative StressEndocrinologyHistone deacetylasePhosphodiesterase 4 InhibitorsPulmonesReactive Oxygen SpeciesRolipramGlucocorticoidmedicine.drugAllergy
researchProduct

Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative…

2010

Background Oral deferiprone was suggested to be more effective than subcutaneous desferrioxamine for removing heart iron. Oral once-daily chelator deferasirox has recently been made commercially available but its long-term efficacy on cardiac iron and function has not yet been established. Our study aimed to compare the effectiveness of deferasirox, deferiprone and desferrioxamine on myocardial and liver iron concentrations and bi-ventricular function in thalassemia major patients by means of quantitative magnetic resonance imaging. Design and Methods From the first 550 thalassemia subjects enrolled in the Myocardial Iron Overload in Thalassemia network, we retrospectively selected thalasse…

medicine.medical_specialtyLiver Iron ConcentrationthalassemiaThalassemiairon chelation therapycardiac magnetic resonance imagingGastroenterologythalassemia; iron chelation therapy; cardiac magnetic resonance imagingNOchemistry.chemical_compoundCardiac magnetic resonance imagingInternal medicinemedicinemedicine.diagnostic_testbusiness.industryDeferasiroxBeta thalassemiaMagnetic resonance imagingHematologymedicine.diseaseSurgeryDeferoxaminechemistrybusinessDeferipronemedicine.drug
researchProduct

Neuronal and extraneuronal uptake and efflux of catecholamines in the isolated rabbit heart

1974

1. Isolated rabbit hearts were perfused with (−)-noradrenaline, (−)-adrenaline and (±)-isoprenaline for various time periods (1–180 min) and then washed with an amine-free medium. The venous concentration of the amine was estimated fluorimetrically during the infusion and after its end, to study removal and efflux, respectively. 2. In untreated hearts and after pretreatment with reserpine the removal had a constant rate over 20–60 min. After pretreatment with pargyline to block monoamine oxidase (MAO), however, the removal of noradrenaline declined exponentially to zero. Inhibition of the neuronal uptake (desipramine) and chemical sympathectomy (6-hydroxydopamine) abolished the removal of n…

medicine.medical_specialtyMonoamine Oxidase InhibitorsReserpineTime FactorsEpinephrineMonoamine oxidaseStimulationModels BiologicalHydroxydopaminesNorepinephrineCatecholaminesHeart RateDesipramineIsoprenalineInternal medicinemedicineAnimalsNeuronsPharmacologyChemistryMyocardiumDesipramineIsoproterenolGeneral MedicineCompartment (chemistry)ReserpinePargylinePerfusionEndocrinologyPargylineRabbitsEffluxHalf-Lifemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Bronchodilator and anti-inflammatory activities of SCA40: studies in human isolated bronchus, human eosinophils, and in the guinea-pig in vivo.

1998

There is currently interest in the use of inhibitors of cyclic nucleotide phosphodiesterases (PDE) as potential anti-asthma agents. In this study we examined the effects of SCA40 (6-bromo-8-methylaminoimidazol-[1,2-a] pyrazine-2-carbonitrile), a preferential inhibitor of PDE 3 also endowed with PDE 4 and 5 inhibitory activities, on isolated bronchus and eosinophil functions and in an animal model of asthma. SCA40 (1 nM-0.1 mM) produced concentration-dependent inhibition of spontaneous and stimulated tone of human isolated bronchus and reached a maximal relaxation similar to that of theophylline (3 mM). The potency (-log EC50 values) of SCA40 against spontaneous tone (6.52 +/- 0.10) was grea…

medicine.medical_specialtyMuscle RelaxationGuinea PigsBronchiIn Vitro Techniqueschemistry.chemical_compoundIn vivoInternal medicinemedicineAnimalsHumansTheophyllineAntigensRolipramPharmacologyLeukotrieneLeukotriene C4Anti-Inflammatory Agents Non-SteroidalImidazolesMuscle SmoothGeneral MedicineEosinophilLeukotriene C4Bronchodilator AgentsEosinophilsmedicine.anatomical_structureEndocrinologychemistryPyrazinesBronchoconstrictionmedicine.symptomBronchial HyperreactivityHistaminemedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Cardiac complications in thalassemia: noninvasive detection methods and new directions in the clinical management.

2004

The natural history of thalassemia has shown substantial change during these years. This applies for each aspect of the pathology (for example, endocrinological, hepatological and psychological) and also for the pathology that has presented and still presents the main cause of death: myocardial dysfunction. In this review, the pathophysiology of cardiac complications, possible role of myocarditis, new knowledge on pathogenesis, and noninvasive detection methods for iron overload in the heart are pointed out. Prophylaxis of cardiomyopathy and new therapy strategies of myocardial dysfunction, including the impact of the new chelation treatment, are discussed.

medicine.medical_specialtyMyocarditisThalassemiaCardiomyopathychemistry.chemical_compoundInternal medicineInternal MedicineMedicineHumansCause of deathbusiness.industryGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingPathophysiologyNatural historychemistryEchocardiographyCardiologyThalassemiaCardiac complications in thalassemiaCardiology and Cardiovascular MedicinebusinessDeferiproneCardiomyopathiesHeart damage
researchProduct

Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study

2020

Objective: This study aimed to analyze the effects of a six-month therapy with ulipristal acetate (UPA) on myoma size and endometrial thickness in premenopausal women. Material and methods: Seventy-four women undergoing conservative therapy with UPA were enrolled for this study. All women underwent transvaginal ultrasound evaluation to assess the endometrial thickness, and the number and size of myomas at the beginning and after six months. Hysteroscopy and biopsy were performed after six months, if necessary. Results: After six months of treatment, sonographic examination showed a statistically significant (p <.05) reduction of the size of the largest myoma (56.3 ± 5.1 vs. 31.7 ± 10.1 m…

medicine.medical_specialtyNorpregnadienesUterine fibroidsHysteroscopy03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePregnancyUlipristal acetateSelective progesterone receptor modulatorulipristal acetatemedicineHumansProspective Studiesuterine fibroidsProspective cohort studyGynecologyLeiomyomamedicine.diagnostic_testbusiness.industryMetrorrhagiaMyomaselective progesterone receptor modulatormedicine.diseaseMyomachemistryHysteroscopy030220 oncology & carcinogenesisUterine NeoplasmsFemale030211 gastroenterology & hepatologySurgerymedicine.symptombusinessmetrorrhagia
researchProduct